No profile data available.
Viking Therapeutics, Inc. (VKTX) is a healthcare company in the multi-therapeutic drug manufacturing industry, based in San Diego, United States, with about 65 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$359.64 million. Its market capitalization was $3.63 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders.
Viking Therapeutics reported $0 in revenue for fiscal year 2025.
$3.63 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Aspen Pharmacare Holdings Limited (APNHY), CMS (CHSYF), Organon & Co. (OGN), Prestige Consumer Healthcare Inc. (PBH).